Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Wilms Tumor 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Hematologic Neoplasms 1Blast Crisis 1

Interventions

Specimen Handling 2Methods 2Educational Status 2Early Intervention, Educational 2trihexyltetradecylphosphonium chloride 1letermovir 1gamma-Globulins 1Voriconazole 1Vincristine 1Vaccination 1Sirolimus 1Prednisone 1Pharmacogenomic Testing 1Patient Navigation 1Organizational Objectives 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Lenalidomide 1Interviews as Topic 1Infliximab 1Immunoglobulins, Intravenous 1Immunoglobulins 1Health Promotion 1Fluconazole 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Caspofungin 1Carvedilol 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hematologic Neoplasms × Methylprednisolone Acetate × Clear all
NCT04438382 2026-06-02

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Eastern Cooperative Oncology Group

Phase 2 Terminated
1 enrolled 1 chart
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡